Brief: ReproCELL to sign regenerative medical products related license agreements
April 2 (Reuters) - ReproCELL Inc 4978.T
* Says it will sign regenerative medical products related
license
agreements with a JV, MAGiQ Therapeutics Inc, which will be
established by the co, Q Therapeutics, Inc and Mahendra Rao on
April 6
Source text in Japanese:https://goo.gl/D63Wdj
Further company coverage: 4978.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))